News

Cell TherapiesR&D project spotlight: A collaborative approach to developing a universal ddPCR™ assay to detect residual pluripotent stem cells in cell therapy products
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
Press release: Cell and gene therapy clinical trials and preclinical programmesPress release: Cell and gene therapy clinical trials and preclinical programmesRegulatory news - June 2016Regulatory news - June 2016Progress being made in UK regenerative therapies industry says expert reportProgress being made in UK regenerative therapies industry says expert reportRegulatory news - May 2016Regulatory news - May 2016Cell Therapy Manufacturing sign new agreementCell Therapy Manufacturing sign new agreementNew company created to develop novel technology to treat diabetesNew company created to develop novel technology to treat diabetesNew report shows that capacity and capability in cell and gene therapy manufacturing continues to increase in the UKNew report shows that capacity and capability in cell and gene therapy manufacturing continues to increase in the UKCell and Gene Therapy Catapult, UCLB and Imperial Innovations announce positive interim review in ongoing AML WT1 T cell clinical trialCell and Gene Therapy Catapult, UCLB and Imperial Innovations announce positive interim review in ongoing AML WT1 T cell clinical trialCell and Gene Therapy Catapult and Asymptote sign licence agreement for thawing system for cell-based therapiesCell and Gene Therapy Catapult and Asymptote sign licence agreement for thawing system for cell-based therapiesFrameworks for promising therapies with less mature evidence base to secure adoptionFrameworks for promising therapies with less mature evidence base to secure adoptionCell and Gene Therapy Catapult appoints three new Non-Executive Directors to the BoardCell and Gene Therapy Catapult appoints three new Non-Executive Directors to the BoardCell Therapy Catapult is now the Cell and Gene Therapy CatapultCell Therapy Catapult is now the Cell and Gene Therapy Catapult